West Pharmaceutical Services · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← WST

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	0.87	+13.8%	37.7%	0.18	0.15	17.7%	0.08	2.15	0.16	0.02
FY2026 Q1	2026-03-31	0.84	+21.0%	35.1%	0.18	0.14	16.4%	0.05	1.92	0.30	0.02
FY2025 Q4	2025-12-31	0.81	+7.5%	37.8%	0.16	0.13	16.4%	0.18	1.82	0.00	0.02
FY2025 Q3	2025-09-30	0.80	+7.7%	36.6%	0.17	0.14	17.4%	0.13	1.92	0.00	0.02
FY2025 Q2	2025-06-30	0.77	+9.2%	35.7%	0.15	0.13	17.2%	0.10	1.82	0.00	0.02
FY2025 Q1	2025-03-31	0.70	+0.4%	33.2%	0.11	0.09	12.9%	0.06	1.23	0.13	0.02
FY2024 Q4	2024-12-31	0.75	+2.3%	36.5%	0.16	0.13	17.4%	0.09	1.78	0.05	0.02
FY2024 Q3	2024-09-30	0.75	−0.1%	35.4%	0.16	0.14	18.2%	0.10	1.85	0.05	0.01
FY2024 Q2	2024-06-30	0.70	−6.9%	32.8%	0.13	0.11	15.9%	0.06	1.51	0.19	0.01
FY2024 Q1	2024-03-31	0.70	−3.0%	33.1%	0.12	0.12	16.6%	0.03	1.55	0.27	0.01
FY2023 Q4	2023-12-31	0.73	+3.3%	38.0%	0.16	0.14	18.7%	0.13	1.83	0.18	0.01
FY2023 Q3	2023-09-30	0.75	+8.8%	38.6%	0.18	0.16	21.6%	0.13	2.14	0.03	0.01
FY2023 Q2	2023-06-30	0.75	—	38.7%	0.18	0.16	20.6%	0.09	2.06	0.17	0.01
FY2023 Q1	2023-03-31	0.72	—	37.9%	0.16	0.14	19.5%	0.06	1.85	0.06	0.01
FY2022 Q4	2022-12-31	0.71	—	37.0%	0.13	0.10	14.5%	0.14	1.37	-0.00	0.01
FY2022 Q3	2022-09-30	0.69	—	39.0%	0.19	0.12	17.6%	0.11	1.59	0.03	0.01

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.